Liraglutide (LRT) Peptide
-
- 抗原
- Liraglutide (LRT)
- 资源
- 合成
- 应用范围
- Control Peptide (CP)
- 产品特性
- control peptide, blocking peptide, acylated glucagon-like peptide-1, diabetes research peptide, GLP-1 analogue
- 纯度
- Greater than 95% specific peptide.
-
- 应用备注
-
Application Note: Liraglutide (GLP 7-37,pal) Control Peptide is suitable for use in ELISA, Western Blot, Dot blot, PCA, and other assays. Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay. Specific conditions for reactivity should be optimized by the end user.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
-
Reconstitution Volume: 1.0 mL
Reconstitution Buffer: Restore with deionized water (or equivalent)
- 浓度
- 1.0 mg/mL
- 储存液
- Without preservative
- 储存条件
- RT,4 °C,-20 °C
- 有效期
- 12 months
-
- 抗原
- Liraglutide (LRT)
-